ESMO 2022 | Cost and immune-related adverse events in patients with sarcoma treated with immunotherapy

Erlinda Gordon, MD, Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA, provides an overview of challenges associated with the use of immunotherapy in patients with sarcoma including cost, as well as strategies employed to improve access to therapies. Dr Gordon also discusses the incidence of immune-related toxicities. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.”